Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Current Deferred Revenue: 2020-2025

Historic Current Deferred Revenue for Beam Therapeutics (BEAM) over the last 5 years, with Sep 2025 value amounting to $110.3 million.

  • Beam Therapeutics' Current Deferred Revenue rose 23.50% to $110.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.3 million, marking a year-over-year increase of 23.50%. This contributed to the annual value of $108.9 million for FY2024, which is 39.05% down from last year.
  • Per Beam Therapeutics' latest filing, its Current Deferred Revenue stood at $110.3 million for Q3 2025, which was up 4.25% from $105.8 million recorded in Q2 2025.
  • Beam Therapeutics' Current Deferred Revenue's 5-year high stood at $348.6 million during Q4 2021, with a 5-year trough of $10.0 million in Q2 2021.
  • Its 3-year average for Current Deferred Revenue is $115.5 million, with a median of $108.9 million in 2024.
  • As far as peak fluctuations go, Beam Therapeutics' Current Deferred Revenue spiked by 1,452,287.50% in 2021, and later tumbled by 49.48% in 2024.
  • Quarterly analysis of 5 years shows Beam Therapeutics' Current Deferred Revenue stood at $348.6 million in 2021, then declined by 2.99% to $338.2 million in 2022, then plummeted by 47.19% to $178.6 million in 2023, then slumped by 39.05% to $108.9 million in 2024, then grew by 23.50% to $110.3 million in 2025.
  • Its last three reported values are $110.3 million in Q3 2025, $105.8 million for Q2 2025, and $85.2 million during Q1 2025.